Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - DEPRECIATION & AMORTIZATION
Depreciation & Amortization APLS - Apellis Pharmaceuticals, Inc.
1.7 M
LAST VALUE
6.87%
2 YEAR CAGR
0.00%
5 YEAR CAGR
75.17%
10 YEAR CAGR